Duowin
Country: Greece
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
13-03-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Permethrin 1.88 % 188 %, Pyriproxyfen 0.02% 2 %
Available from:
Virbac S.A.
ATC code:
QP53AC0
Therapeutic group:
permethrin
Therapeutic area:
Dogs Non Food
Authorization date:
2011-03-18
Summary of Product characteristics
Revised: March 2011
AN: 01719/2010
1/5
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
DUOWIN, Cutaneous Spray, Solution.
(ES : DOGLY, solución para pulverización cutánea en perros )
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
FOR 100 ML :
ACTIVE SUBSTANCES :
Permethrin (Cis:Trans 40:60) ..................................................................................................
1.88
g
Pyripro xy fen................................................................................................................................
20
mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Cutaneous spray, solution.
Clear and pale yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES
TREATMENT AND PREVENTION OF FLEA (_CTENOCEPHALIDES FELIS_) AND TICK (_RHIPICEPHALUS _
_SANGUINEUS, IXODES RICINUS_) INFESTATIONS.
Against fleas:
Treatment and prevention of a new infestation by adult fleas for 6 weeks.
Prevention of flea multiplication for 10 weeks by sterilizing the eggs.
Against ticks:
Treatment and prevention of a new infestation for 4 weeks.
4.3
CONTRAINDICATIONS
Do not use on cats.
See also sections 4.5. and 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
FLAMMABLE.
Keep treated animals away from fires and other sources of heat for at least 30 minutes following
spraying and until the fur is totally dry.
Underdosing should be avoided in order to maintain the claimed duration of efficacy.
Care should be taken to accurately weigh the animal and to comply with the recommended number of
activations of
Read the complete document
